Sho Tsuji

Tsuji-san is a seasoned veteran of the Japanese medical device industry and brings over 38 years of rich experience in building teams, businesses and networks.

After starting out with pharmaceuticals in 1980, Tsuji-san found a passion for medical devices and soon was at the early beginnings of angiography as a sales rep for Tyco Japan. He was an active and early leader, building the business by first covering Tokyo and Eastern Japan, further expanding out through the early strategic use of subdistributors. His savvy approach led to a doubling of sales in the first two years, and soon he was a well-recognized face with countless cardiologists and later neurosurgeons nationwide. Tsuji-san was an early believer and promoter of clinical education, serving as an establishing member behind the development of formalized, nationwide seminars providing physicians with solid training and education on the most cutting-edge devices and procedures. He then joined the highly respected Japanese device importer/distributor/manufacturer Japan LifeLine where he again soon excelled as interventional product specialist.  Driving business growth through thorough sales rep training while also continuing to closely support and work with key physicians, his success-proven approach to the effective and strategic implementation of clinical education was an industry-wide recognized strength. After over 25 years in leadership positions at Japan LifeLine, and having overseen multiple new product releases and strategic growth plans for products from companies such as BALT, Scimed, Nipro, Kaneka, Angiosonics and AVE, Tsuji-san left the company to establish the medical device consulting firm M-AT. Here he was free to support numerous global companies in optimizing new product launches and further drive business growth, continuing his focus on interventional therapeutic devices including DES and other cutting-edge technologies. Tsuji-san now works with MedMarket Access, LLC and continues to have intimate knowledge on coronary and peripheral markets, as well as maintaining his healthy network of key physicians and industry leaders earned over decades of close interaction.

​